Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning

Abstract Background There is no consensus regarding the clinical target volume (CTV) margins in radiotherapy for glioma. In this study, we aimed to perform a complete macropathologic analysis examining microscopic tumor extension (ME) to more accurately define the CTV in glioma. Methods Thirty-eight...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Shulun Nie, Yufang Zhu, Jia Yang, Tao Xin, Song Xue, Jujie Sun, Dianbin Mu, Zhaoqiu Chen, Pengpeng Sun, Jinming Yu, Man Hu
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Glioma Microscopic extension Radiotherapy Clinical target volume Medicine R
Acceso en línea:	https://doaj.org/article/672b722471b44516a1bdc69f8339a5ab
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:672b722471b44516a1bdc69f8339a5ab
record_format	dspace
spelling	oai:doaj.org-article:672b722471b44516a1bdc69f8339a5ab2021-11-21T12:16:04ZClinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning10.1186/s12916-021-02143-w1741-7015https://doaj.org/article/672b722471b44516a1bdc69f8339a5ab2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12916-021-02143-whttps://doaj.org/toc/1741-7015Abstract Background There is no consensus regarding the clinical target volume (CTV) margins in radiotherapy for glioma. In this study, we aimed to perform a complete macropathologic analysis examining microscopic tumor extension (ME) to more accurately define the CTV in glioma. Methods Thirty-eight supra-total resection specimens of glioma patients were examined on histologic sections. The ME distance, defined as the maximum linear distance from the tumor border to the invasive tumor cells, was measured at each section. We defined the CTV based on the relationships between ME distance and clinicopathologic features. Results Between February 2016 and July 2020, a total of 814 slides were examined, corresponding to 162 slides for low-grade glioma (LGG) and 652 slides for high-grade glioma (HGG). The ME value was 0.69 ± 0.43 cm for LGG and 1.29 ± 0.54 cm for HGG (P < 0.001). After multivariate analysis, tumor grade, O6-methylguanine-DNA-methyltransferase promoter methylated status (MGMTm), isocitrate dehydrogenase wild-type status (IDHwt), and 1p/19q non-co-deleted status (non-codel) were positively correlated with ME distance (all P < 0.05). We defined the CTV of glioma based on tumor grade. To take into account approximately 95% of the ME, a margin of 1.00 cm, 1.50 cm, and 2.00 cm were chosen for grade II, grade III, and grade IV glioma, respectively. Paired analysis of molecularly defined patients confirmed that tumors that had all three molecular alterations (i.e., MGMTm/IDHwt/non-codel) were the most aggressive subgroups (all P < 0.05). For these patients, the margin could be up to 1.50 cm, 2.00 cm, and 2.50 cm for grade II, grade III, and grade IV glioma, respectively, to cover the subclinical lesions in 95% of cases. Conclusions The ME was different between the grades of gliomas. It may be reasonable to recommend 1.00 cm, 1.50 cm, and 2.00 cm CTV margins for grade II, grade III, and grade IV glioma, respectively. Considering the highly aggressive nature of MGMTm/IDHwt/non-codel tumors, for these patients, the margin could be further expanded by 0.5 cm. These recommendations would encompass microscopic disease extension in 95% of cases. Trial registration The trial was registered with Chinese Clinical Trial Registry ( ChiCTR2100049376 ).Shulun NieYufang ZhuJia YangTao XinSong XueJujie SunDianbin MuZhaoqiu ChenPengpeng SunJinming YuMan HuBMCarticleGliomaMicroscopic extensionRadiotherapyClinical target volumeMedicineRENBMC Medicine, Vol 19, Iss 1, Pp 1-13 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Glioma Microscopic extension Radiotherapy Clinical target volume Medicine R
spellingShingle	Glioma Microscopic extension Radiotherapy Clinical target volume Medicine R Shulun Nie Yufang Zhu Jia Yang Tao Xin Song Xue Jujie Sun Dianbin Mu Zhaoqiu Chen Pengpeng Sun Jinming Yu Man Hu Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
description	Abstract Background There is no consensus regarding the clinical target volume (CTV) margins in radiotherapy for glioma. In this study, we aimed to perform a complete macropathologic analysis examining microscopic tumor extension (ME) to more accurately define the CTV in glioma. Methods Thirty-eight supra-total resection specimens of glioma patients were examined on histologic sections. The ME distance, defined as the maximum linear distance from the tumor border to the invasive tumor cells, was measured at each section. We defined the CTV based on the relationships between ME distance and clinicopathologic features. Results Between February 2016 and July 2020, a total of 814 slides were examined, corresponding to 162 slides for low-grade glioma (LGG) and 652 slides for high-grade glioma (HGG). The ME value was 0.69 ± 0.43 cm for LGG and 1.29 ± 0.54 cm for HGG (P < 0.001). After multivariate analysis, tumor grade, O6-methylguanine-DNA-methyltransferase promoter methylated status (MGMTm), isocitrate dehydrogenase wild-type status (IDHwt), and 1p/19q non-co-deleted status (non-codel) were positively correlated with ME distance (all P < 0.05). We defined the CTV of glioma based on tumor grade. To take into account approximately 95% of the ME, a margin of 1.00 cm, 1.50 cm, and 2.00 cm were chosen for grade II, grade III, and grade IV glioma, respectively. Paired analysis of molecularly defined patients confirmed that tumors that had all three molecular alterations (i.e., MGMTm/IDHwt/non-codel) were the most aggressive subgroups (all P < 0.05). For these patients, the margin could be up to 1.50 cm, 2.00 cm, and 2.50 cm for grade II, grade III, and grade IV glioma, respectively, to cover the subclinical lesions in 95% of cases. Conclusions The ME was different between the grades of gliomas. It may be reasonable to recommend 1.00 cm, 1.50 cm, and 2.00 cm CTV margins for grade II, grade III, and grade IV glioma, respectively. Considering the highly aggressive nature of MGMTm/IDHwt/non-codel tumors, for these patients, the margin could be further expanded by 0.5 cm. These recommendations would encompass microscopic disease extension in 95% of cases. Trial registration The trial was registered with Chinese Clinical Trial Registry ( ChiCTR2100049376 ).
format	article
author	Shulun Nie Yufang Zhu Jia Yang Tao Xin Song Xue Jujie Sun Dianbin Mu Zhaoqiu Chen Pengpeng Sun Jinming Yu Man Hu
author_facet	Shulun Nie Yufang Zhu Jia Yang Tao Xin Song Xue Jujie Sun Dianbin Mu Zhaoqiu Chen Pengpeng Sun Jinming Yu Man Hu
author_sort	Shulun Nie
title	Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
title_short	Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
title_full	Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
title_fullStr	Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
title_full_unstemmed	Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
title_sort	clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning
publisher	BMC
publishDate	2021
url	https://doaj.org/article/672b722471b44516a1bdc69f8339a5ab
work_keys_str_mv	AT shulunnie clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT yufangzhu clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT jiayang clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT taoxin clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT songxue clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT jujiesun clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT dianbinmu clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT zhaoqiuchen clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT pengpengsun clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT jinmingyu clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning AT manhu clinicopathologicanalysisofmicroscopictumorextensioningliomaforexternalbeamradiotherapyplanning
_version_	1718419126458777600

Clinicopathologic analysis of microscopic tumor extension in glioma for external beam radiotherapy planning

Ejemplares similares